MulderLab
Delen
The MulderLab spans two research teams, at Radboud University Medical Center and Eindhoven University of Technology, working on establishing nanotech-based immunotherapeutics. Nano-TMII is directed by Dr. Willem Mulder and is funded by the National Heart Lung and Blood Institute, the National Cancer Institute and NHLBI’s Program of Excellence in Nanotechnology. The mission of Nano-TMII is to devel
04/12/2020
Very nice blog on our recent cell paper:
Nanoparticle Trains Immune Cells to Attack Cancer Researchers have developed a nanoparticle that trains immune cells to attack cancer. By inducing this trained immunity, the nanoparticle slowed the growth of melanoma in mice, according to the NCI-funded study, and was more effective when combined with an immune checkpoint inhibitor.
25/11/2020
Our work is featured in the Arabic version of Scientific American Magazine:
العلاج المناعي للسرطان.. تغيير قواعد اللعبة باحثون يدربون الخلايا المناعية كي تهاجم الخلايا & #1575...
16/10/2020
We just received the proof of a highly anticipated paper that will be dropping in two weeks. It will be about cancer, trained immunity, nanotech and immunotherapy.
Feel free to checkout the new website of our startup, the continuation of that work:
https://ttxdiscovery.com
Klik hier om uitgelicht te worden.
Type
Website
Adres
Den Dolech 2
Eindhoven
5600MB
